Compounds > hydralazine

hydralazine and berotek

hydralazine has been researched along with berotek in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	4 (57.14)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
de Champlain, J; Moreau, P; Yamaguchi, N	1
de Champlain, J; Drolet, G; Moreau, P; Yamaguchi, N	1

Other Studies

7 other study(ies) available for hydralazine and berotek

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Enhanced presynaptic beta 2-adrenergic facilitatory mechanism in conscious deoxycorticosterone acetate-salt hypertensive rats. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6 Topics: Animals; Blood Pressure; Desoxycorticosterone; Epinephrine; Fenoterol; Heart Rate; Hydralazine; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Neurotransmitter; Sodium Chloride	1991
Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension. American journal of hypertension, 1993, Volume: 6, Issue:12 Topics: Adrenalectomy; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Catecholamines; Desoxycorticosterone; Fenoterol; Heart Rate; Hemorrhage; Hydralazine; Hypertension; Male; Nitroprusside; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Receptors, Presynaptic; Sodium Chloride; Sympathetic Nervous System; Synaptic Transmission	1993